Bertrand C. Liang Net Worth

The estimated Net Worth of Bertrand C. Liang is at least $297 Million dollars as of 1 December 2015. Bertrand Liang owns over 5,000 units of Pfenex stock worth over $295,611,263 and over the last 14 years Bertrand sold PFNX stock worth over $926,300.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Bertrand Liang PFNX stock SEC Form 4 insiders trading

Bertrand has made over 10 trades of the Pfenex stock since 2015, according to the Form 4 filled with the SEC. Most recently Bertrand sold 5,000 units of PFNX stock worth $74,400 on 1 December 2015.

The largest trade Bertrand's ever made was selling 10,000 units of Pfenex stock on 2 March 2015 worth over $143,200. On average, Bertrand trades about 3,929 units every 20 days since 2010. As of 1 December 2015 Bertrand still owns at least 522,466 units of Pfenex stock.

You can see the complete history of Bertrand Liang stock trades at the bottom of the page.

What's Bertrand Liang's mailing address?

Bertrand's mailing address filed with the SEC is C/O PFENEX INC., 10790 ROSELLE STREET, , SAN DIEGO, CA, 92121.

Insiders trading at Pfenex

Over the last 10 years, insiders at Pfenex have traded over $99,496,796 worth of Pfenex stock and bought 36,000 units worth $174,640 . The most active insiders traders include Chemical Co /De/ Dow, James C Gale, and Healthcare Partners Accredi.... On average, Pfenex executives and independent directors trade stock every 46 days with the average trade being worth of $90,240,574. The most recent stock trade was executed by Asset Management Lpweiss An... on 29 September 2020, trading 100,000 units of PFNX stock currently worth $1,274,000.

What does Pfenex do?

Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.

Complete history of Bertrand Liang stock trades at La Jolla Pharmaceutical Co and Pfenex

Pfenex executives and stock owners

Pfenex executives and other stock owners filed with the SEC include:

• Shawn Scranton,
  Chief Operating Officer
• Susan A. Knudson,
  Chief Financial Officer
• Evert B. Schimmelpennink,
  See Remarks
• Patricia Lady,
  Chief Accounting Officer
• Jason Grenfell Gardner,
  Director
• Martin Brenner,
  Chief Scientific Officer
• Magda Marquet,
  Director
• Phillip M Schneider,
  Director
• Sigurdur O Olafsson,
  Director
• Hubert C Chen,
  Chief Medical Officer
• John Mack Taylor,
  Director
• Patrick K. Lucy,
  Chief Business Officer
• Robin Campbell,
  Director
• Lorianne Masuoka,
  Director
• Dennis M Fenton,
  Director
• William R Rohn,
  Director
• Henry W. Jr. Talbot,
  VP of Research & Operations
• Healthcare Partners Accredi...,
  10% owner
• Bertrand C. Liang,
  Chief Executive Officer
• Steven S. Sr. Sandoval,
  Chief Manufacturing Officer
• Paul A. Wagner,
  Chief Financial Officer
• Chemical Co /De/ Dow,
  10% owner
• Healthcare Partners Accredi...,
  
• James C Gale,
  Director
• Asset Management Lpweiss An...,
  
• Management, Llc Newtyn,
  10% owner